Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?
Authors: Dimitrios Patoulias, Michael Doumas
Published: 2020-09-25
DOI:
10.3350/cmh.2020.0264
Source:
Full article
Abstract
No abstract found.